Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs targeted at growing the horizons of cytokine-based immunotherapy, specifically for cancers where therapy choices remain limited. Utilize the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Examine Our Pipeline We https://financefeeds.com/primexbt-acquires-fsca-license-to-launch-operations-in-south-africa/